Showing results (11-20 of 295) with videos related to

Sort By:
Pageof 30
Respiratory Investigation|September 8, 2015
Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumoniaShinji Teramoto, Kazufumi Yoshida, Nobuyuki Hizawa
Internal Medicine (Tokyo, Japan)|January 14, 2005
Increased neutrophils in bronchoalveolar lavage fluids from a patient with pulmonary edema associated with pheochromocytomaNoriaki Sukoh, Nobuyuki Hizawa, Hiroshi Yamamoto, et al.
Respiratory Investigation|September 14, 2023
Patient profiling to predict response to bronchial thermoplasty in patients with severe asthmaSatoshi Ano, Norihiro Kikuchi, Masashi Matsuyama, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 2, 2005
Roles of functional polymorphisms in the interleukin-18 gene promoter in sarcoidosisYanqiu Zhou, Etsuro Yamaguchi, Nobuyuki Hizawa, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|November 30, 2006
Osteopontin: a potential biomarker for successful bee venom immunotherapy and a potential molecule for inhibiting IgE-mediated allergic responsesSatoshi Konno, Nobuyuki Hizawa, Masaharu Nishimura, et al.
COPD|January 9, 2020
Effects of Lung Function-Related Genes and TSLP on COPD PhenotypesHideyasu Yamada, Norihito Hida, Hironori Masuko, et al.
Contemporary Oncology (Poznan, Poland)|November 16, 2022
Distant organ metastasis patterns in lung cancer patients with pancreatic metastasis - a cluster analysisShinichiro Okauchi, Kunihiko Miyazaki, Toshihiro Shiozawa, et al.
Arerugi = [Allergy]|January 28, 2005
[Evaluation of antigen specific IgE responses in Japanese asthmatics and non-asthmatics]Daisuke Takahashi, Nobuyuki Hizawa, Yukiko Maeda, et al.
Molecular and Clinical Oncology|July 8, 2017
Modified glasgow prognostic score in patients with small-cell lung cancerKoichi Kurishima, Hiroko Watanabe, Hiroichi Ishikawa, et al.
Molecular and Clinical Oncology|July 8, 2017
A retrospective study of docetaxel and bevacizumab as a second- or later-line chemotherapy for non-small cell lung cancerKoichi Kurishima, Hiroko Watanabe, Hiroichi Ishikawa, et al.
Pageof 30